Blood Brain Barrier Impairment in HIV-Positive Naïve and Effectively Treated Patients: Immune Activation Versus Astrocytosis. (Q40458885)

20 September 2017

title

Blood Brain Barrier Impairment in HIV-Positive Naïve and Effectively Treated Patients: Immune Activation Versus Astrocytosis. (English)

1 reference

20 September 2017

1 reference

A Calcagno

1

1 reference

20 September 2017

A Romito

2

1 reference

20 September 2017

C Atzori

3

1 reference

20 September 2017

V Ghisetti

4

1 reference

20 September 2017

C Cardellino

5

1 reference

20 September 2017

S Audagnotto

6

1 reference

20 September 2017

E Scarvaglieri

7

1 reference

20 September 2017

F Lipani

8

1 reference

20 September 2017

D Imperiale

9

1 reference

20 September 2017

G Di Perri

10

1 reference

20 September 2017

S Bonora

11

1 reference

20 September 2017

language of work or name

1 reference

8 November 2016

1 reference

Journal of Neuroimmune Pharmacology

20 September 2017

published in

1 reference

Increased blood-brain barrier permeability in neuro-asymptomatic HIV-1-infected individuals--correlation with cerebrospinal fluid HIV-1 RNA and neopterin levels

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

Updated research nosology for HIV-associated neurocognitive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

Prevalence and predictors of blood-brain barrier damage in the HAART era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

Peripheral blood mononuclear cells HIV DNA levels impact intermittently on neurocognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV individuals - a cross-sectional observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

Marked increase of the astrocytic marker S100B in the cerebrospinal fluid of HIV-infected patients on LPV/r-monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

Biological and methodological features of the measurement of S100B, a putative marker of brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

Increased S100β in the cerebrospinal fluid of patients with frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

Acquired immunodeficiency syndrome and the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

Intraventricular infusion of the neurotrophic protein S100B improves cognitive recovery after fluid percussion injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

Controversies in HIV-associated neurocognitive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

Antiretroviral monocyte efficacy score linked to cognitive impairment in HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

Cytokine secretion from brain macrophages infected with human immunodeficiency virus in vitro and treated with raltegravir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

HIV-associated deficits in action (verb) generation may reflect astrocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

Astrocyte activation and memory impairment in the repetitive febrile seizures model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

Neuropathogenesis of HIV: from initial neuroinvasion to HIV-associated neurocognitive disorder (HAND)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

Factors Associated With Virological Failure in HIV-1–Infected Patients Receiving Darunavir/Ritonavir Monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11481-016-9717-2

External quality assessment in clinical neurochemistry: survey of analysis for cerebrospinal fluid (CSF) proteins based on CSF/serum quotients

21 January 2018

1 reference

12 December 2020

Albumin induces upregulation of matrix metalloproteinase-9 in astrocytes via MAPK and reactive oxygen species-dependent pathways

1 reference

12 December 2020

HIV-1 RNA levels in the cerebrospinal fluid may increase owing to damage to the blood-brain barrier.

1 reference

12 December 2020

Cerebrospinal fluid S-100beta and its relationship with AIDS dementia complex

1 reference

12 December 2020

10.1007/S11481-016-9717-2

Identifiers

DOI

0 references

1 reference